insights_auto
Why is BOT up 25.00%?
Dive Deeperchevron_right
BOT:ASX
Botanix Pharmaceuticals Ltd
A$0.010
arrow_upward
+25.00%(+0.0020) 1D
Nov 17, 4:10:06 PM GMT+11 · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for BOT...
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
10.87M
Volume
10.30M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
Open
A$0.01
High
A$0.01
Low
A$0.01
Mkt. cap
24.86M
Avg. vol.
10.87M
Volume
10.30M
52-wk high
A$0.15
52-wk low
A$0.01
EPS
-A$0.03
Shares outstanding
2.76B
No. of employees
11
News stories
From web sources and news partners
Yahoo Finance
·
1 hour ago
Stock Market: Will S&P 500 Open Up or Down Today?
The Motley Fool
·
16 hours ago
Is an Equal-Weight S&P 500 Fund Safer Right Now Than the One You Own?
ChartMill
·
13 hours ago
Today's S&P 500 Top Movers: Tyson Foods Leads Gainers, Lumentum Leads Decliners
Traders Union
·
8 hours ago
Michael A. Gayed: S&P 500 fell 19.35% and high yield dropped 5.9% in Q4 2018 selloff
Profile
Botanix Pharmaceuticals is listed on the Australian Securities Exchange with the issue code BOT. The Company is headquartered in Perth, Western Australia and Philadelphia, USA. It is a clinical stage synthetic cannabinoid company, focusing on the compound Cannabidiol. The company's lead product is Sofdra, which treats axillary hyperhidrosis. The company has two separate development platforms, dermatology and antimicrobial. Botanix also has an exclusive license to use a proprietary drug delivery system Permetrex, for direct skin delivery of active pharmaceuticals which is utilised in all of their programs. Wikipedia
About Botanix Pharmaceuticals Ltd
CEO-
Employees11
Founded1984
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websitebotanixpharma.com